Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine.
The post US FDA finds control lapses at Moderna manufacturing plant appeared first on Reuters News Agency.